Verification evidence is still being completed.
4bases SA
Manno, Switzerland
- Verified lead
- Fabio Grandi
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- CE-IVD NGS Reagent Kits, Genetic Diagnostic Protocols, and Clinical Sequencing Pipelines
- Review cycle
- 24 April 2026
- Full address
- Manno, Ticino, Switzerland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- GenomeWeb coverage of 4bases naming Fabio Grandi as CEO.
- Editorial note
- Ticino NGS diagnostics specialist with named CEO, roughly two dozen CE-IVD NGS kits, and a Platomics partnership supporting IVDR workflow documentation.
CE-IVD NGS Reagent Kits, Genetic Diagnostic Protocols, and Clinical Sequencing Pipelines
CE-IVD NGS kit portfolio, Platomics IVDR partnership, Swiss Biotech Association listing
Ticino NGS diagnostics specialist with named CEO, roughly two dozen CE-IVD NGS kits, and a Platomics partnership supporting IVDR workflow documentation.
4bases SA
CE-IVD NGS Reagent Kits, Genetic Diagnostic Protocols, and Clinical Sequencing Pipelines · CE-IVD reagent kit manufacturing
Ticino NGS diagnostics specialist with named CEO, roughly two dozen CE-IVD NGS kits, and a Platomics partnership supporting IVDR workflow documentation.
- Lead
- Fabio Grandi (verified ↗)
- Address
- Manno, Ticino, Switzerland (source ↗)
- Compliance
- CE-IVD NGS kit portfolio
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- CE-IVD reagent kit manufacturing
- Capabilities
- CE-IVD NGS Library Prep Kits · Analysis Software and Pipelines · Diagnostic Protocol Development
- Founded
- 2014
- Headcount
- 1-10
- Company page (open ↗)
Fabio Grandi
Chief Executive Officer
CE-IVD reagent kit manufacturing
Manno, Switzerland. CE-IVD NGS Reagent Kits, Genetic Diagnostic Protocols, and Clinical Sequencing Pipelines. Review completed on 24 Apr 2026.
Swissmedic and EU IVDR for diagnostic oversight
CE-IVD NGS kit portfolio, Platomics IVDR partnership, Swiss Biotech Association listing
CE-IVD NGS Reagent Kits, Genetic Diagnostic Protocols, and Clinical Sequencing Pipelines
Ticino NGS diagnostics specialist with named CEO, roughly two dozen CE-IVD NGS kits, and a Platomics partnership supporting IVDR workflow documentation.
4bases is a Ticino-headquartered NGS diagnostics specialist with a named CEO, approximately two dozen CE-IVD marked NGS kits, and a Platomics partnership for IVDR laboratory workflow documentation.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- VERIFIED ACTIVE 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is 4bases SA located?
- 4bases SA operates from Manno, Ticino, Switzerland, Manno, Switzerland.
- Who runs 4bases SA?
- 4bases SA is led by Fabio Grandi, Chief Executive Officer. Verified 24 Apr 2026.
- What certifications does 4bases SA hold?
- 4bases SA is documented under CE-IVD NGS kit portfolio.
- What does 4bases SA do?
- Ticino NGS diagnostics specialist with named CEO, roughly two dozen CE-IVD NGS kits, and a Platomics partnership supporting IVDR workflow documentation. Core capabilities: CE-IVD NGS Library Prep Kits, Analysis Software and Pipelines, Diagnostic Protocol Development.
Related technical briefs
Briefs that name Manno as a covered market or city.
